The authors wish to make the following corrections to this paper: [1].
There was a mistake in Figure 3 as published. Figure 3c must be substituted with the following one. The corrected Figure 3 is presented below.
Figure 3.
(a,b) The cytotoxicity of CS-TPP-ALG NPs, CS-TPP-ALG carrier, and exenatide in Caco-2 cells after 24 h (a) and 72 h (b). (c) Intracellular distribution of Rho-CS-TPP-ALG NPs in Caco-2 cells. Cells were exposed to Rhodamine B, Rho-CS, and Rho-CS-TPP-ALG NPs at 37 °C for 4 h, the concentration of fluorescence was 1 µg/mL.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Yang, J.-M.; Wu, L.-J.; Lin, M.-T.; Lu, Y.-Y.; Wang, T.-T.; Han, M.; Zhang, B.; Xu, D.-H. Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats. Polymers 2022, 14, 2181. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).